Target intelligence / Profile preview

Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D)

Target
TNFRSF10D
Molecular classification
Receptor, Tumor necrosis factor receptor superfamily, Cell surface receptor
01

Overview

Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D), also known as Decoy receptor 2 (DCR2) or TRAIL receptor 4 (TRAILR4), is a cell surface receptor belonging to the TNF receptor superfamily[1][3][7]. Unlike related pro-apoptotic receptors, TNFRSF10D contains a truncated cytoplasmic death domain, rendering it incapable of inducing apoptosis; instead, it acts as a decoy receptor that binds TRAIL, thereby inhibiting TRAIL-induced cell death and modulating immune and apoptotic responses[1][3][4][6]. TNFRSF10D is implicated in a range of cancers, both as a marker of tumor progression and as a regulator of tumor sensitivity to TRAIL-based therapies, with its epigenetic silencing associated with tumorigenesis in several cancer types[1][2].

Other names
Decoy receptor 2TRAIL receptor 4TRAILR4DCR2CD264TRUNDD
02

Mechanism of action

Acts as a decoy receptor for TRAIL (TNF-related apoptosis-inducing ligand), inhibiting TRAIL-induced apoptosis by competing with pro-apoptotic TRAIL receptors for ligand binding[1][3][4][6].

03

Biological functions

Negative regulation of apoptosisSignal transductionModulation of TRAIL signalingRegulation of cell survival
04

Disease associations

CancerTumorigenesisNeuroblastomaBreast cancerProstate cancerLung cancerImmune response regulation
05

Safety considerations

Potential for resistance to TRAIL-based therapies due to its anti-apoptotic (decoy) activity[1][2]Loss or inactivation of this gene may increase sensitivity to apoptotic therapies, but could also disrupt normal regulatory functions
06

Interacting drugs

None specifically approved or widely characterized; TRAIL-based investigational therapies may be indirectly affected due to this receptor’s decoy function
07

Biomarkers

Hypermethylation of the TNFRSF10D promoter (e.g., in melanoma or cervical cancer)[1]Expression levels as a prognostic biomarker in certain cancers[2]

Beyond the preview

Go deeper on Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call